KINETA, INC./DE
Profile
Company Names
KINETA, INC./DE
YUMANITY THERAPEUTICS, INC.
PROTEOSTASIS THERAPEUTICS, INC.
PROTEOSTASIS THERAPEUTICS INC
Addresses
219 TERRY AVE. N., SUITE 300, SEATTLE, WA 98109-5208
40 GUEST STREET, SUITE 4410, BOSTON, MA 02135
200 TECHNOLOGY SQUARE, CAMBRIDGE, MA 02139
200 TECHNOLOGY SQUARE, SUITE 402, CAMBRIDGE, MA 02139
Phone Numbers
(206) 378-0400
617-409-5300
617-225-0096
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, OTHER HEALTH CARE
Year Incorporated:
2006
State Incorporated:
DELAWARE
Total Amount Raised:
$148,722,887.00
Number of Funding Rounds:
6
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
6
2023-10-03
$0.00
$2,893,176.00
$2,893,176.00
5
2022-12-16
$7,500,000.00
$30,000,000.00
$22,500,000.00
Equity
4
2020-12-22
$33,599,895.00
$33,599,895.00
$0.00
Equity
3
2015-09-01
$21,999,992.00
$27,999,992.00
$6,000,000.00
Equity
2
2014-07-31
$15,000,000.00
$15,000,000.00
$0.00
Debt
1
2008-08-15
$70,623,000.00
$81,760,000.00
$11,137,000.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICIA
L.
ALLEN
DIRECTOR
DAVID
ARKOWITZ
DIRECTOR
M.
JAMES
BARRETT
DIRECTOR
MICHAEL
CASEY
EXECUTIVE OFFICER
PINKBERRY HOLDING CORP
| BLUE PILLAR INC
| RENENUE PARTICIPATION INVESTORS NO. 1, LLC
| SELECTICA INC
| BREP EUROPE IV (ALBERTA) L.P.
| BLACKSTONE REAL ESTATE PARTNERS EUROPE IV L.P.
| PRIMEXX ENERGY OPPORTUNITY FUND, LP
| BREP EUROPE IV FEEDER B L.P.
| PROTEOSTASIS THERAPEUTICS, INC.
| BLACKSTONE REAL ESTATE PARTNERS VIII L.P.
| BLACKSTONE REAL ESTATE PARTNERS VIII.F L.P.
| DETERMINE, INC.
| LOGFIRE, INC.
| BLACKSTONE EDISON MANAGED PARTNERS L.P.
| BREP EUROPE V (ALBERTA) L.P.
| BLACKSTONE REAL ESTATE PARTNERS EUROPE V L.P.
| BLACKSTONE EDISON MANAGED PARTNERS.TE L.P.
| PRIMEXX ENERGY OPPORTUNITY FUND II, LP
| WTC FUNDAMENTAL OPPORTUNISTIC CREDIT FUND, LLC
| WHITTIER CORPORATE AMERICA FUND, LP
| WHITTIER ODYSSEY FUND, LP
| BLACKSTONE REAL ESTATE PARTNERS ASIA II L.P.
| BREP ASIA II FEEDER L.P.
| BLACKSTONE REAL ESTATE PARTNERS ASIA II (LUX) SCSP
| WTC PRIVATE DEBT FUND, LLC
| BLACKSTONE PROPERTY PARTNERS ASIA FEEDER I L.P.
| BLACKSTONE PROPERTY PARTNERS ASIA FEEDER II L.P.
| BLACKSTONE PROPERTY PARTNERS ASIA FEEDER (OP) IV L.P.
| POWERFLEET, INC.
| FIRST STATE HOLDING CO.
| DATAMONKEY, INC.
| MMF II 8PCT REIT FEEDER LP
| SGIF III (WT), LLC
BERNARD
DAVITIAN
DIRECTOR
KIM
C.
DRAPKIN
DIRECTOR
MARION
R.
FOOTE
DIRECTOR
JEFFREY
GOLDBERG
EXECUTIVE OFFICER
PROTEOSTASIS THERAPEUTICS, INC.
| AKCEA THERAPEUTICS, INC.
| NEURVANA MEDICAL, LLC
| NEW MMI HOLDINGS, INC.
| BALLYHOO MEDIA, INC.
| STIMWAVE TECHNOLOGIES INC
| IMMUNITAS THERAPEUTICS, INC.
| MREI VI BLOCKER FEEDER, LP
| MILESTONE REAL ESTATE INVESTORS VI, LP
| MREI VI REIT FEEDER A, LP
| MREI VI REIT FEEDER C, LP
| MREI VI REIT FEEDER D, LP
| MREI VI REIT B, LP
| MREI VI REIT C, LP
| MREI VI REIT A, LP
| MREI VI REIT D, LP
| HIGHER GROUND LLC
| MREI VI BLOCKER FEEDER A, LP
| MREI VI REIT FEEDER B, LP
| MREI VI REIT FEEDER E, LP
| MREI VI BLOCKER FEEDER B, LP
| MREI VI REIT E, LP
| TERRAFLOW ENERGY, INC.
RICHARD
A.
HEYMAN
DIRECTOR
SHAWN
IADONATO
EXECUTIVE OFFICER, DIRECTOR
JEFFERY
KELLY
DIRECTOR
JEFFERY
W.
KELLY
DIRECTOR
STEPHEN
KNIGHT
DIRECTOR
IRENA
MELNIKOVA
PROMOTER
CHRISTOPHER
MIRABELLI
DIRECTOR
CHRISTOPHER
K.
MIRABELLI
DIRECTOR
RICHARD
PETERS
DIRECTOR, EXECUTIVE OFFICER
LAUREN
SILVERMAN
DIRECTOR
HENRY
SKINNER
DIRECTOR
AVILA THERAPEUTICS INC
| THESAN PHARMACEUTICALS, INC.
| AEGLEA BIOTHERAPEUTICS HOLDINGS, LLC
| GALERA THERAPEUTICS, INC.
| AEGLEA BIOTHERAPEUTICS, INC.
| PROTEOSTASIS THERAPEUTICS, INC.
| MACROLIDE PHARMACEUTICALS, INC.
| CAVION, INC.
| NEUROVIA, INC.
| GENOMEDX INC.
| CURASEN THERAPEUTICS, INC.
| DECIPHER BIOSCIENCES, INC.
CHRISTOPHER
WALSH
DIRECTOR
CHRISTOPHER
T.
WALSH
DIRECTOR
LYNNE
ZYDOWSKY
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2022-12-16
D
OTHER HEALTH CARE
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2020-12-22
D/A
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2014-07-31
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2015-09-01

